.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Teva
Citi
Cerilliant
Fuji
US Department of Justice
Accenture
Novartis
Chinese Patent Office
Colorcon

Generated: December 18, 2017

DrugPatentWatch Database Preview

ACETAZOLAMIDE SODIUM Drug Profile

« Back to Dashboard

When do Acetazolamide Sodium patents expire, and when can generic versions of Acetazolamide Sodium launch?

Acetazolamide Sodium is a drug marketed by Hospira, Par Sterile Products, Sagent Agila, West-ward Pharms Int, X Gen Pharms, and Emcure Pharms Ltd. and is included in six NDAs.

The generic ingredient in ACETAZOLAMIDE SODIUM is acetazolamide sodium. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.
Drug patent expirations by year for ACETAZOLAMIDE SODIUM

Pharmacology for ACETAZOLAMIDE SODIUM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
HospiraACETAZOLAMIDE SODIUMacetazolamide sodiumINJECTABLE;INJECTION040108-001Oct 30, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntACETAZOLAMIDE SODIUMacetazolamide sodiumINJECTABLE;INJECTION040089-001Feb 28, 1995APRXNoNo► Subscribe► Subscribe► Subscribe
Par Sterile ProductsACETAZOLAMIDE SODIUMacetazolamide sodiumINJECTABLE;INJECTION205358-001Jun 20, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Sagent AgilaACETAZOLAMIDE SODIUMacetazolamide sodiumINJECTABLE;INJECTION200880-001May 9, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Emcure Pharms LtdACETAZOLAMIDE SODIUM acetazolamide sodiumINJECTABLE;INJECTION202693-001Dec 19, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
X Gen PharmsACETAZOLAMIDE SODIUMacetazolamide sodiumINJECTABLE;INJECTION040784-001Dec 10, 2008APRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Novartis
Argus Health
Baxter
Medtronic
Teva
Boehringer Ingelheim
Cipla
Julphar
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot